v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Millions
Total
Total Stockholders’ Equity
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interest
Common stock, beginning balance (in shares) at Dec. 31, 2024     503,777,464        
Beginning balance at Dec. 31, 2024 $ 752.6 $ 752.6 $ 0.1 $ 2,438.4 $ (1,685.6) $ (0.3) $ 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Class A common stock (in shares)     1,906,161        
Issuance of Class A common stock 16.7 16.7   16.7      
Issuance of RSU and restricted stock expense (in shares)     4,544,253        
Issuance of RSU and restricted stock expense 1.9 1.9   1.9      
Exercise of stock options (in shares)     168,510        
Exercise of stock options 0.0 0.0          
Issuance of warrants and warrant expense 0.8 0.8   0.8      
Exercise of warrants (in shares)     3,000        
Exercise of warrants, net 0.0 0.0          
PIPE financing (in shares)     2,982,089        
PIPE financing 9.6 9.6   9.6      
Registered Direct Offering (in shares)     35,500,000        
Registered Direct Offering 289.5 289.5   289.5      
Stock-based compensation 33.5 33.5   33.5      
Net loss (93.4) (93.4)     (93.4)    
Other comprehensive (loss) income 0.1 0.1       0.1 0.0
Common stock, ending balance (in shares) at Mar. 31, 2025     548,881,477        
Ending balance at Mar. 31, 2025 1,011.3 1,011.3 $ 0.1 2,790.4 (1,779.0) (0.2) 0.0
Common stock, beginning balance (in shares) at Dec. 31, 2024     503,777,464        
Beginning balance at Dec. 31, 2024 752.6 752.6 $ 0.1 2,438.4 (1,685.6) (0.3) 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Class A common stock (in shares)     4,331,384        
Issuance of Class A common stock     $ 40.2        
Net loss (299.4)            
Other comprehensive (loss) income 0.2            
Common stock, ending balance (in shares) at Jun. 30, 2025     640,636,644        
Ending balance at Jun. 30, 2025 1,680.9 1,680.9 $ 0.1 3,665.9 (1,985.0) (0.1) 0.0
Common stock, beginning balance (in shares) at Mar. 31, 2025     548,881,477        
Beginning balance at Mar. 31, 2025 1,011.3 1,011.3 $ 0.1 2,790.4 (1,779.0) (0.2) 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Class A common stock (in shares)     2,425,223        
Issuance of Class A common stock 23.5 23.5 $ 23.5 23.5      
Issuance of RSU and restricted stock expense (in shares)     3,613,804        
Issuance of RSU and restricted stock expense 0.5 0.5   0.5      
Exercise of stock options (in shares)     97,967        
Exercise of stock options 0.0 0.0          
Issuance of warrants and warrant expense 0.8 0.8   0.8      
Common stock issued under ESPP (in shares)     618,173        
Common stock issued under ESPP 3.9 3.9   3.9      
Registered Direct Offering (in shares)     85,000,000        
Registered Direct Offering 816.8 816.8   816.8      
Stock-based compensation 30.0 30.0   30.0      
Net loss (206.0) (206.0)     (206.0)    
Other comprehensive (loss) income 0.1 0.1       0.1 0.0
Common stock, ending balance (in shares) at Jun. 30, 2025     640,636,644        
Ending balance at Jun. 30, 2025 $ 1,680.9 1,680.9 $ 0.1 3,665.9 (1,985.0) (0.1) 0.0
Common stock, beginning balance (in shares) at Dec. 31, 2025 744,000,000.0   744,046,194        
Beginning balance at Dec. 31, 2025 $ 2,202.8 2,202.8 $ 0.1 4,507.9 (2,303.8) (1.4) 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Class A common stock (in shares)     6,547,560        
Issuance of Class A common stock 42.1 42.1   42.1      
Issuance of RSU and restricted stock expense (in shares)     6,484,721        
Issuance of RSU and restricted stock expense 1.8 1.8   1.8      
Exercise of stock options (in shares)     348,957        
Exercise of stock options 0.1 0.1   0.1      
Issuance of warrants and warrant expense 1.8 1.8   1.8      
Exercise of warrants (in shares)     142,450        
Exercise of warrants, net 0.0 0.0          
Issuance of Class A common stock in connection with business acquisition (in shares)     341,984        
Issuance of Class A common stock in connection with business acquisition 2.9 2.9   2.9      
Stock-based compensation 47.4 47.4   47.4      
Net loss (217.7) (217.7)     (217.7)    
Other comprehensive (loss) income (1.8) (1.8)       (1.8) 0.0
Common stock, ending balance (in shares) at Mar. 31, 2026     757,911,866        
Ending balance at Mar. 31, 2026 $ 2,079.4 2,079.4 $ 0.1 4,604.0 (2,521.5) (3.2) 0.0
Common stock, beginning balance (in shares) at Dec. 31, 2025 744,000,000.0   744,046,194        
Beginning balance at Dec. 31, 2025 $ 2,202.8 2,202.8 $ 0.1 4,507.9 (2,303.8) (1.4) 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Class A common stock (in shares)     11,093,897        
Issuance of Class A common stock     $ 70.6        
Exercise of stock options (in shares) 529,690            
Net loss $ (480.9)            
Other comprehensive (loss) income $ (2.2)            
Common stock, ending balance (in shares) at Jun. 30, 2026 770,000,000.0   770,005,721        
Ending balance at Jun. 30, 2026 $ 1,915.6 1,892.3 $ 0.1 4,680.5 (2,784.7) (3.6) 23.3
Common stock, beginning balance (in shares) at Mar. 31, 2026     757,911,866        
Beginning balance at Mar. 31, 2026 2,079.4 2,079.4 $ 0.1 4,604.0 (2,521.5) (3.2) 0.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Class A common stock (in shares)     4,546,337        
Issuance of Class A common stock 28.5 28.5 $ 28.5 28.5      
Issuance of RSU and restricted stock expense (in shares)     4,797,429        
Issuance of RSU and restricted stock expense 0.0 0.0   0.0      
Exercise of stock options (in shares)     180,733        
Exercise of stock options 0.0 0.0   0.0      
Issuance of warrants and warrant expense 0.5 0.5   0.5      
Exercise of warrants (in shares)     1,669,783        
Exercise of warrants, net 0.0 0.0          
Common stock issued under ESPP (in shares)     899,573        
Common stock issued under ESPP 5.2 5.2   5.2      
Business acquisition with noncontrolling interest 23.3 0.0         23.3
Stock-based compensation 42.3 42.3   42.3      
Net loss (263.2) (263.2)     (263.2)    
Other comprehensive (loss) income $ (0.4) (0.4)       (0.4) 0.0
Common stock, ending balance (in shares) at Jun. 30, 2026 770,000,000.0   770,005,721        
Ending balance at Jun. 30, 2026 $ 1,915.6 $ 1,892.3 $ 0.1 $ 4,680.5 $ (2,784.7) $ (3.6) $ 23.3